Valuation: DexCom, Inc.

Market Cap 31.74B 28.45B 26.49B 24.03B 45.32B 3,039B 45.62B 318B 125B 1,566B 119B 117B 5,034B P/E 2026 *
33.8x
P/E 2027 * 28.5x
Enterprise Value 30.98B 27.77B 25.85B 23.46B 44.23B 2,967B 44.53B 311B 122B 1,528B 116B 114B 4,913B EV / Sales 2026 *
5.92x
EV / Sales 2027 * 5.29x
Free-Float
91.27%
Yield 2026 *
-
Yield 2027 * -
1 day+2.15%
1 week-1.13%
Current month-0.43%
1 month+3.48%
3 months+14.62%
6 months+34.21%
Current year+29.46%
1 week 82.94
Extreme 82.935
86.1
1 month 82.86
Extreme 82.86
90.38
Current year 56.72
Extreme 56.72
92.59
1 year 54.11
Extreme 54.11
92.59
3 years 54.11
Extreme 54.11
142
5 years 54.11
Extreme 54.11
164.86
10 years 10.66
Extreme 10.655
164.86
Manager TitleAgeSince
Chief Executive Officer 47 2025-12-31
Director of Finance/CFO 46 2021-03-18
Chief Tech/Sci/R&D Officer - 2024-04-30
Director TitleAgeSince
Chairman 68 2018-07-29
Director/Board Member 67 2009-11-19
Director/Board Member 47 2025-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
9/28/26 Sell

Head of Human Resources

-2,565 0.0007%
9/15/26 Sell

Compliance Officer

-1,700 0.0005%
9/15/26 Sell

Director

-6,539 0.0017%
Change 5-day change 1-year change 3-year change Capi.($)
+2.15%-1.13%+31.94%+13.82% 31.74B
+2.23%+1.72%-23.20%+12.89% 172B
+3.90%+4.50%-3.69%+28.95% 113B
+1.90%-0.92%-22.49%+11.33% 106B
+0.27%+1.56%-46.32%-11.83% 75.31B
+0.37%+3.22%+2.22%+73.30% 61.8B
+0.12%+3.62%+15.06%+62.75% 52.93B
+2.80%+4.55%+1.25%-26.52% 50.05B
+1.15%-0.59%-14.97%+22.33% 40.81B
-1.38%-0.11% - - 31.81B
Average +0.89%+2.04%-6.69%+20.78% 73.64B
Weighted average by Cap. +1.04%+2.17%-12.63%+19.43%

Financials

2026 *2027 *
Net sales 5.23B 4.69B 4.36B 3.96B 7.47B 501B 7.52B 52.48B 20.54B 258B 19.64B 19.21B 830B 5.8B 5.2B 4.84B 4.39B 8.28B 555B 8.34B 58.2B 22.77B 286B 21.78B 21.3B 920B
Net income 974M 873M 813M 738M 1.39B 93.3B 1.4B 9.78B 3.83B 48.06B 3.66B 3.58B 155B 1.15B 1.03B 959M 870M 1.64B 110B 1.65B 11.53B 4.51B 56.68B 4.31B 4.22B 182B
Net Debt -761M -682M -635M -576M -1.09B -72.89B -1.09B -7.64B -2.99B -37.55B -2.86B -2.8B -121B -1.06B -951M -886M -804M -1.52B -102B -1.53B -10.65B -4.17B -52.36B -3.99B -3.9B -168B
Projected Income Statement - Annual - DexCom, Inc.
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
26-10-12 US$85.92 +2.15% 2,890,194
26-10-09 US$84.11 -0.36% 3,154,204
26-10-08 US$84.41 +0.13% 3,607,110
26-10-07 US$84.30 +1.09% 2,863,835
26-10-06 US$83.39 -4.04% 3,574,805
Trader
Investor
Global
Quality
ESG MSCI
BBB
Ratings Surperformance© - DexCom, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
84.11USD
Average target price
96.23USD
Spread / Average Target
+14.41%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - DexCom, Inc.
  1. Stock Market
  2. Stocks
  3. DXCM Stock